Clinical Trial Update: Effects of PS-IPC Supplementation on Muscle Mass and Functional Outcomes in Older Adults [NA]

View source ↗

Summary

Clinical trial update on PS-IPC supplementation and its effects on muscle mass and functional outcomes in older adults. The trial status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcopenia

Drugs mentioned

• PS-IPC Supplementation

Snippet

Sponsor: University of Arkansas | Conditions: Immune Senescence, Sarcopenia | NA | Status: TERMINATED